Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery
3/31/2014 8:33:09 AM
PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against membrane protein targets. Lipoparticles are an enabling technology for the company’s MPS Discovery Engine™ for isolating monoclonal antibodies (MAbs) against membrane protein targets. Lipoparticles are used to generate conformationally-sensitive, inhibitory MAbs against targets such as GPCRs, ion channels and transporters. U.S. Patent No. 8,680,244 was issued by the U.S. Patent and Trademark Office on March 25, 2014, further strengthening the intellectual property position of the MPS platform for the discovery of antibody therapeutics.
Help employers find you! Check out all the jobs and post your resume.
comments powered by